Idelalisib

Overview

Idelalisib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2216870).

API suppliers (2)

Suppliers of Idelalisib backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Natco PharmaIndia1 active DMF
• Lupin LimitedIndia

Patent & exclusivity (US)

Per the FDA Orange Book (4 approved US products), the latest listed US patent on Idelalisib expires 2 Sept 2033. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one

Canonical SMILES

CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5

InChIKey

IFSDAJWBUCMOAH-HNNXBMFYSA-N